Postoperative Treatment With Angiotensin-Converting Enzyme Inhibitors in Patients With Preoperative Reduced Left Ventricular Systolic Function

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 2, 2008, Pages 187-191

  Villacorta, Judith ^a   Oddoze, Chistiane ^b   Giorgi, Roch ^c   Kerbaul, François ^a   Bonnet, Marc ^a   Collart, Frédéric ^a   Gouin, François ^a   Guidon, Catherine ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c LERTIM Faculté de Médecine   (France)

Author keywords

angiotensin converting enzyme inhibitors; brain natriuretic peptide; cardiac surgery; left ventricular dysfunction; ramipril

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; RAMIPRIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SUBSTITUTION; ELECTIVE SURGERY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; MALE; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 41049094963     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.06.004     Document Type: Article

References (37)

1. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327 (1992) 669-677
2. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
3. Pfeffer M.A., Greaves S.C., Arnold J.M., et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and afterload-reducing therapy trial. Circulation 95 (1997) 2643-2651
4. Mair J., Friedl W., Thomas S., et al. Natriuretic peptides of assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl 230 (1999) 132-142
5. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
6. Lainchbury J.G., Troughton R.W., Frampton C.M., et al. NTproBNP-guided drug treatment for chronic heart failure: Design and methods in the "BATTLESCARRED" trial. Eur J Heart Fail 8 (2006) 532-538
7. Hutfless R., Kazanegra R., Madani M., et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43 (2004) 1873-1879
8. Selvais P.L., Donckier J.E., Robert A., et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest 28 (1998) 636-642
9. Wieczorek S.J., Wu A.H., Christenson R., et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation. Am Heart J 144 (2002) 834-839
10. de Lemos J.A., and Morrow D.A. Brain natriuretic peptide measurement in acute coronary syndromes. Ready for clinical application?. Circulation 106 (2002) 2868-2870
11. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
12. Chello M., Mastroroberto P., Perticone F., et al. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur J Cardiothoracic Surg 20 (2001) 140-146
13. Morimoto K., Mori T., Ishiguro S., et al. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today 28 (1998) 23-29
14. Provenchère S., Berroeta C., Reynaud C., et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 34 (2006) 995-1000
15. Pfister R., Scholz M., Wielckens K., et al. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6 (2004) 289-293
16. Phua J., Lim T.K., and Lee K.H. B-type natriuretic peptide/Issues for the intensivist and pulmonologist. Crit Care Med 33 (2005) 2094-2103
17. Conlon P.J., Stafford-Smith M., White W.D., et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14 (1992) 1158-1162
18. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
19. Dries D.L., Exner D.V., Domanski M.J., et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
20. Provenchère S., Plantefève G., Hufnagel G., et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: Incidence, risk factors, and effect on clinical outcome. Anesth Analg 96 (2003) 1258-1264
21. Hillege H.L., Van Gilst W.H., Van Veldhuisen D.J., et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: The CATS randomized trial. Eur Heart J 24 (2003) 412-420
22. Royston D. High-dose aprotinin therapy: A review of the first five years' experience. J Cardiothorac Vasc Anesth 6 (1992) 76-100
23. Royster R.L., Butterworth IV J.F., Prough D.S., et al. Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass grafting. Anesth Analg 72 (1991) 729-736
24. Romson J.L., Leung J.M., Bellows W.H., et al. Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients. Anesthesiology 91 (1999) 1318-1328
25. Rawlins M.L., Owen W.E., and Roberts W.L. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 123 (2005) 439-445
26. Butterworth IV J.F., Legault C., Royster R.L., et al. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg 86 (1998) 461-467
27. Müller M., Junger A., Bräu M., et al. Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system. Br J Anaesth 89 (2002) 398-404
28. Feneck R.O., Sherry K.M., Withington P.S., et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 12 (2001) 306-315
29. Torp-Pedersen C., Køber L., and Carlsen J. Angiotensin-converting enzyme inhibition after myocardial infarction: The Trandolapril Cardiac Evaluation study. Am Heart J 132 (1996) 235-243
30. GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Soprawivenza nell'infarto Miocardico. Lancet 343 (1994) 1115-1122
31. ISIS-4. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 345 (1995) 669-682
32. Webb C.M., Underwood R., Anagnostopoulos C., et al. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery-A randomised study. Eur J Cardiothorac Surg 13 (1998) 42-48
33. Manché A., Galea J., and Busuttil W. Tolerance to ACE inhibitors after cardiac surgery. Eur J Cardiothorac Surg 15 (1999) 55-60
34. Cuthbertson B.H., McKeown A., Croal B.L., et al. Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 33 (2005) 437-442
35. Georges A., Forestier F., Valli N., et al. Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur J Cardiothorac Surg 25 (2004) 941-945
36. Mair P., Mair J., Bleier J., et al. Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest. Clin Chim Acta 261 (1997) 57-68
37. Kerbaul F., Giorgi R., Oddoze C., et al. High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery. Br J Anaesth 93 (2004) 639-644